Agree and I added a good parcel today. That quarterly is a good read, and their partner names in Roche and infineon via Blumio don't get any better. Pretty clear there is a lot going on too, re studies and COVID effects and revenues not too bad either. Some interesting appointments that you would not make if you were not confident.
Long term hold and happy to add here. Close to inflexion point. Some work to do for price to get through 3.7 to 4.2 area with lots of jaded holders but after 4.2/4.3 , prior highs are on.
